Araştırma Makalesi
BibTex RIS Kaynak Göster

Antibiotic Susceptibilities of Group B Streptococci

Yıl 2011, Cilt: 28 Sayı: 1, 1 - 3, 15.02.2012

Aziz Dilek Hasan Kesbiç Nursel Dilek

Öz

Streptococcus agalactiae is a frequent cause of serious infections in newborn babies. It has increasingly been recognized as a pathogen in nonpregnant adults. Penicillin and ampicillin are the drugs of choice for treatment of group B streptococcus (GBS) infections. Widespread use of these antibiotics has potentated the emergence of antibiotic resistance. Total 56 isolates included in the study were recovered from vaginal swabs and ürine samples. Isolates were tested for antimicrobial susceptibility by Kirby-Bauer disk diffusion susceptibility testing method. All of the 56 clinical isolates tested were fully susceptible to penicillin, ampicillin and cephalothin. Only 8 (14.2%) and 6 (10.7%) were resistant to erythromycin and clindamycin, respectively. All of the 56 clinical isolates were not susceptible to tetracycline.

Anahtar Kelimeler

Streptococcus agalactiae group B streptococcus penicilin erythromycin tetracycline ciprofloxacin

Kaynakça

  • Al-Sweih, N., Jamal, M., Kurdia, M., Abduljabar, R., Rotimi, V. 2005. Antibiotic susceptibility profile of group B streptococcus (streptococ- cusagalactiae ) at the Maternity Hospital, Kuwait. Med. Princ. Pract.14, 260–263.
  • Betriu, C., Culebras, E., Gomez, M., Rodríguez-Avial, I., Sanchez, B.A., Agreda, M.C., Picazo, J.J. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in streptococcus agalactiae. Antimicrob. Agents Ch. 47, 1112–1114.
  • De Mouy, D., Cavallo, J.D., Leclercq, R., Fabre, R. The Aforcopı-Bıo Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical ısolates of streptococcus agalactiae: french multicenter study. Antimicrob. Agents Ch. 45, 2400–2402.
  • Elbaradie, S.M.Y., Mahmoud, M., Farid, M. 2009. Maternal and neonatal screening for group B streptococci by SCPB gene based PCR: a pre liminary study. Indian J. Med. Microbi. 27, 17-21.
  • Figueira-Coelho, J., Ramirez, M., Salgado, M.J., Melo-Cristino, J. 2004. Streptococcus agalactiae in a large portuguese teaching hospital: anti- microbial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant ısolates. Microb. Drug Resist. 10, 31-36.
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. 2004. Antibiotic susceptibility in neonatal invasive isolates of streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Ch. 48, 4444–4446.
  • Karakus, M., Karaca, D.Y., Günçiner, Ş. 2007. Colonization and antimicrobial resistance patern of group B streptococcus in pregnant women. Ege J. Med. 46, 151 -154.
  • Kawamura, Y., Fujiwara, H., Mishima, N., Tanaka, Y., Tanimoto, A., Ikawa, S., Itoh Y., Ezaki, T. 2003. First streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Ch. 47, 3605-3609
  • Kraśnianin, E., Skret-Magierło, J., Witalis, J., Barnaś, E., Kluz, T., Kozieł, A., Skret, A. 2009. The incidence of streptococcus group b in 100 parturient women and the transmission of pathogens to the newborn. Ginekol. Pol. 80, 285-289.
  • Kulkarni, A.A., Pawar, S.G., Dharmadhikari, C.A., Kulkarni, R.D. 2001. Colonization of pregnant women and their newborn infants with group-B streptococci. Indian J. Med. Microbi. 19, 1-4.
  • Money, D.M., Dobson, S. 2004. The prevention of early-onset neonatal group B streptococcal disease. J. Obstet. Gynaecol. Can. 26, 826–832.
  • Monique, T.S., Jan, K., Louis, K., Bakkers, J., Melchers, W., Spanjaard, L., Wannet, W.J., Hoogkamp-Korstanje, M.A. 2006. Serotypes, geno types and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitisbefore and after introduction of antibiotic prophylaxis. Pediatr. Infect. Dis. J. 25, 945-948.
  • Moyo, S.R., Maeland, J.A., Bergh, K. 2002. Typing of human isolates of streptococcus agalactiae (group B streptococcus, gbs) strains from Zimbabwe. J. Med. Microbiol. 51, 595–600.
  • Ölçü, M., Eşel, D. 2007. Antibiotic susceptibilities of clinical streptococcus agalactiae isolates. J. Health Sci. 16, 23-27. 3 Dilek et al.
  • Schrag, S.J., Phil, D., Zywicki, S. Farley, M.M., Reingold, A.L., Harrison, L.H., Lefkowitz, L.B., Hadler, J.L., Danila, R., Cieslak, P.R., Schuchat, A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342, 15-20.
  • Topkaya, A., Küçükercan, M., Oğuzoğlu, N., Ünal, N., Narin, K. 2003. Antibiotic susceptibilities of group B streptococci isolated from vaginal and rectal colonization in pregnant women. J. Turk. Microbi. Society. 33, 242-245.
  • Tünger, A., Çavuşoğlu, C., Korkmaz, M. 2005. Group B streptococcus. Asya Microbi. 94-96.
  • Quiroga, M., Pegels, E., Oviedo, P., Pereyra, E., Vergara, M. 2008. Antibiotic susceptibility patterns and prevalence of group B streptococcus isolated from pregnant women in misiones, Argentina. Brazilian J. Microbi. 39, 245-25.

Yıl 2011, Cilt: 28 Sayı: 1, 1 - 3, 15.02.2012

Aziz Dilek Hasan Kesbiç Nursel Dilek

Öz

Kaynakça

  • Al-Sweih, N., Jamal, M., Kurdia, M., Abduljabar, R., Rotimi, V. 2005. Antibiotic susceptibility profile of group B streptococcus (streptococ- cusagalactiae ) at the Maternity Hospital, Kuwait. Med. Princ. Pract.14, 260–263.
  • Betriu, C., Culebras, E., Gomez, M., Rodríguez-Avial, I., Sanchez, B.A., Agreda, M.C., Picazo, J.J. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in streptococcus agalactiae. Antimicrob. Agents Ch. 47, 1112–1114.
  • De Mouy, D., Cavallo, J.D., Leclercq, R., Fabre, R. The Aforcopı-Bıo Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical ısolates of streptococcus agalactiae: french multicenter study. Antimicrob. Agents Ch. 45, 2400–2402.
  • Elbaradie, S.M.Y., Mahmoud, M., Farid, M. 2009. Maternal and neonatal screening for group B streptococci by SCPB gene based PCR: a pre liminary study. Indian J. Med. Microbi. 27, 17-21.
  • Figueira-Coelho, J., Ramirez, M., Salgado, M.J., Melo-Cristino, J. 2004. Streptococcus agalactiae in a large portuguese teaching hospital: anti- microbial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant ısolates. Microb. Drug Resist. 10, 31-36.
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. 2004. Antibiotic susceptibility in neonatal invasive isolates of streptococcus agalactiae in a 2-year nationwide surveillance study in Germany. Antimicrob. Agents Ch. 48, 4444–4446.
  • Karakus, M., Karaca, D.Y., Günçiner, Ş. 2007. Colonization and antimicrobial resistance patern of group B streptococcus in pregnant women. Ege J. Med. 46, 151 -154.
  • Kawamura, Y., Fujiwara, H., Mishima, N., Tanaka, Y., Tanimoto, A., Ikawa, S., Itoh Y., Ezaki, T. 2003. First streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC. Antimicrob. Agents Ch. 47, 3605-3609
  • Kraśnianin, E., Skret-Magierło, J., Witalis, J., Barnaś, E., Kluz, T., Kozieł, A., Skret, A. 2009. The incidence of streptococcus group b in 100 parturient women and the transmission of pathogens to the newborn. Ginekol. Pol. 80, 285-289.
  • Kulkarni, A.A., Pawar, S.G., Dharmadhikari, C.A., Kulkarni, R.D. 2001. Colonization of pregnant women and their newborn infants with group-B streptococci. Indian J. Med. Microbi. 19, 1-4.
  • Money, D.M., Dobson, S. 2004. The prevention of early-onset neonatal group B streptococcal disease. J. Obstet. Gynaecol. Can. 26, 826–832.
  • Monique, T.S., Jan, K., Louis, K., Bakkers, J., Melchers, W., Spanjaard, L., Wannet, W.J., Hoogkamp-Korstanje, M.A. 2006. Serotypes, geno types and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitisbefore and after introduction of antibiotic prophylaxis. Pediatr. Infect. Dis. J. 25, 945-948.
  • Moyo, S.R., Maeland, J.A., Bergh, K. 2002. Typing of human isolates of streptococcus agalactiae (group B streptococcus, gbs) strains from Zimbabwe. J. Med. Microbiol. 51, 595–600.
  • Ölçü, M., Eşel, D. 2007. Antibiotic susceptibilities of clinical streptococcus agalactiae isolates. J. Health Sci. 16, 23-27. 3 Dilek et al.
  • Schrag, S.J., Phil, D., Zywicki, S. Farley, M.M., Reingold, A.L., Harrison, L.H., Lefkowitz, L.B., Hadler, J.L., Danila, R., Cieslak, P.R., Schuchat, A. 2000. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N. Engl. J. Med. 342, 15-20.
  • Topkaya, A., Küçükercan, M., Oğuzoğlu, N., Ünal, N., Narin, K. 2003. Antibiotic susceptibilities of group B streptococci isolated from vaginal and rectal colonization in pregnant women. J. Turk. Microbi. Society. 33, 242-245.
  • Tünger, A., Çavuşoğlu, C., Korkmaz, M. 2005. Group B streptococcus. Asya Microbi. 94-96.
  • Quiroga, M., Pegels, E., Oviedo, P., Pereyra, E., Vergara, M. 2008. Antibiotic susceptibility patterns and prevalence of group B streptococcus isolated from pregnant women in misiones, Argentina. Brazilian J. Microbi. 39, 245-25.
Toplam 18 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Basic Medical Sciences
Yazarlar

Aziz Dilek

Hasan Kesbiç Bu kişi benim

Nursel Dilek

Yayımlanma Tarihi 15 Şubat 2012
Gönderilme Tarihi 22 Aralık 2010
Yayımlandığı Sayı Yıl 2011 Cilt: 28 Sayı: 1

Kaynak Göster

APA Dilek, A., Kesbiç, H., & Dilek, N. (2012). Antibiotic Susceptibilities of Group B Streptococci. Journal of Experimental and Clinical Medicine, 28(1), 1-3.
AMA Dilek A, Kesbiç H, Dilek N. Antibiotic Susceptibilities of Group B Streptococci. J. Exp. Clin. Med. Şubat 2012;28(1):1-3.
Chicago Dilek, Aziz, Hasan Kesbiç, ve Nursel Dilek. “Antibiotic Susceptibilities of Group B Streptococci”. Journal of Experimental and Clinical Medicine 28, sy. 1 (Şubat 2012): 1-3.
EndNote Dilek A, Kesbiç H, Dilek N (01 Şubat 2012) Antibiotic Susceptibilities of Group B Streptococci. Journal of Experimental and Clinical Medicine 28 1 1–3.
IEEE A. Dilek, H. Kesbiç, ve N. Dilek, “Antibiotic Susceptibilities of Group B Streptococci”, J. Exp. Clin. Med., c. 28, sy. 1, ss. 1–3, 2012.
ISNAD Dilek, Aziz vd. “Antibiotic Susceptibilities of Group B Streptococci”. Journal of Experimental and Clinical Medicine 28/1 (Şubat 2012), 1-3.
JAMA Dilek A, Kesbiç H, Dilek N. Antibiotic Susceptibilities of Group B Streptococci. J. Exp. Clin. Med. 2012;28:1–3.
MLA Dilek, Aziz vd. “Antibiotic Susceptibilities of Group B Streptococci”. Journal of Experimental and Clinical Medicine, c. 28, sy. 1, 2012, ss. 1-3.
Vancouver Dilek A, Kesbiç H, Dilek N. Antibiotic Susceptibilities of Group B Streptococci. J. Exp. Clin. Med. 2012;28(1):1-3.
 Kapak Resmi İndir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.